PortalPublikationenPrimary hypothyroidism resolves after switching from L-thyro...

Primary hypothyroidism resolves after switching from L-thyroxine solid tablets to liquid oral substitution. A rare case without evidence of an underlying gastrointestinal malabsorption syndrome

Standard

Primary hypothyroidism resolves after switching from L-thyroxine solid tablets to liquid oral substitution. A rare case without evidence of an underlying gastrointestinal malabsorption syndrome. / Stupperich, Sophie; Kotliarevskaia, Jessica; Nies, Reinhold; Paparoupa, Maria; Wittig, Andreas; Schuppert, Frank.

in: CLIN CASE REP, Jahrgang 10, Nr. 8, e6223, 08.2022.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Stupperich, S, Kotliarevskaia, J, Nies, R, Paparoupa, M, Wittig, A & Schuppert, F 2022, 'Primary hypothyroidism resolves after switching from L-thyroxine solid tablets to liquid oral substitution. A rare case without evidence of an underlying gastrointestinal malabsorption syndrome', CLIN CASE REP, Jg. 10, Nr. 8, e6223. https://doi.org/10.1002/ccr3.6223

APA

Stupperich, S., Kotliarevskaia, J., Nies, R., Paparoupa, M., Wittig, A., & Schuppert, F. (2022). Primary hypothyroidism resolves after switching from L-thyroxine solid tablets to liquid oral substitution. A rare case without evidence of an underlying gastrointestinal malabsorption syndrome. CLIN CASE REP, 10(8), [e6223]. https://doi.org/10.1002/ccr3.6223

Vancouver

Stupperich S, Kotliarevskaia J, Nies R, Paparoupa M, Wittig A, Schuppert F. Primary hypothyroidism resolves after switching from L-thyroxine solid tablets to liquid oral substitution. A rare case without evidence of an underlying gastrointestinal malabsorption syndrome. CLIN CASE REP. 2022 Aug;10(8). e6223. https://doi.org/10.1002/ccr3.6223

Bibtex

@article{918741a1d663416ea83bc7dda5bcdea4,
title = "Primary hypothyroidism resolves after switching from L-thyroxine solid tablets to liquid oral substitution. A rare case without evidence of an underlying gastrointestinal malabsorption syndrome",
abstract = "A case of refractory primary hypothyroidism is presented. Despite laboratory-guided hormonal substitution, the patient remained hypothyroid. Multiple diagnostic tests ruled out all known causes of levothyroxine malabsorption. Interestingly, clinical and laboratory responding was promptly achieved, after switching the application format from solid tablets to liquid formula.",
author = "Sophie Stupperich and Jessica Kotliarevskaia and Reinhold Nies and Maria Paparoupa and Andreas Wittig and Frank Schuppert",
note = "{\textcopyright} 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.",
year = "2022",
month = aug,
doi = "10.1002/ccr3.6223",
language = "English",
volume = "10",
journal = "CLIN CASE REP",
issn = "2050-0904",
publisher = "John Wiley and Sons Ltd",
number = "8",

}

RIS

TY - JOUR

T1 - Primary hypothyroidism resolves after switching from L-thyroxine solid tablets to liquid oral substitution. A rare case without evidence of an underlying gastrointestinal malabsorption syndrome

AU - Stupperich, Sophie

AU - Kotliarevskaia, Jessica

AU - Nies, Reinhold

AU - Paparoupa, Maria

AU - Wittig, Andreas

AU - Schuppert, Frank

N1 - © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

PY - 2022/8

Y1 - 2022/8

N2 - A case of refractory primary hypothyroidism is presented. Despite laboratory-guided hormonal substitution, the patient remained hypothyroid. Multiple diagnostic tests ruled out all known causes of levothyroxine malabsorption. Interestingly, clinical and laboratory responding was promptly achieved, after switching the application format from solid tablets to liquid formula.

AB - A case of refractory primary hypothyroidism is presented. Despite laboratory-guided hormonal substitution, the patient remained hypothyroid. Multiple diagnostic tests ruled out all known causes of levothyroxine malabsorption. Interestingly, clinical and laboratory responding was promptly achieved, after switching the application format from solid tablets to liquid formula.

U2 - 10.1002/ccr3.6223

DO - 10.1002/ccr3.6223

M3 - SCORING: Journal article

C2 - 35990384

VL - 10

JO - CLIN CASE REP

JF - CLIN CASE REP

SN - 2050-0904

IS - 8

M1 - e6223

ER -